Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Dec 6, 2013

NEW YORK (GenomeWeb News) – SomaLogic has named Byron Hewett to be its new CEO, effective Dec. 2. Hewett takes over the top spot for Larry Gold, who will continue serving in his other post as chairman of the board and working full-time as an adviser.

Hewett most recently was chairman and CEO of Biobehavioral Diagnostics, and he previously was president and CEO of Immunicon and senior VP of sales and marketing and GM, North America for Qiagen. He also has held leadership posts at Abbott Diagnostics, Chiron/Bayer, and BioCircuits.

Sequenom said this week that Ronald Lindsay, the firm's executive VP of strategic planning, will retire from the company at the end of 2013, although he will continue to serve as a member of the firm's board of directors.

Lindsay began working part-time for the firm in August.

NuVasive, a medical device company that develops spinal surgical products and procedures, has appointed Greg Lucier to its board of directors.

Lucier is the chairman and CEO of Life Technologies, which is in the process of being acquired by Thermo Fisher Scientific. He has also held senior management positions at General Electric.

RainDance Technologies has appointed Alfred Merriweather as CFO. He most recently served as CFO of Verinata Health prior to its acquisition by Illumina.

Previously, Merriweather served as CFO and in senior executive positions with several life science and clinical diagnostics companies, including Celera and Monogram Biosciences.

Pamela McInnes has been tapped to be deputy director of the National Center for Advancing Translational Sciences, and she will start in the new role in January. She currently is director of the Division of Extramural Research at the National Institute of Dental and Craniofacial Research.

Before she joined NIDCR, McInnes spent 16 years at the National Institute of Allergy and Infectious Diseases, where she held many positions, including deputy director of its Division of Microbiology and Infectious Diseases. She also was responsible for reorganizing and overseeing the NIAID's Divisional Clinical Research Program where she worked to develop recombinant RPA anthrax vaccines and attenuated smallpox vaccines through collaborations with the US Food and Drug Administration, the Department of Defense, and the Centers for Disease Control and Prevention.

Tute Genomics, which provides a cloud-based clinical genome interpretation pipeline, has appointed Mingfu Zhu as director of bioinformatics.

Zhu was previously an assistant professor at the Center for Human Genome Variation at Duke University Medical Center.

Dirk Evers is now VP of data operations at Molecular Health in Heidelberg, Germany.

Previously, he was senior vice president of informatics at the New York Genome Center and was also the director of computational biology at Illumina.

Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.